![Ken Pastor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ken Pastor
Fundador en CTI Life Sciences Fund .
Cargos activos de Ken Pastor
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GLyPharma Therapeutic, Inc.
![]() GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Inversor de Capital Privado | - | - |
CTI Life Sciences Fund
![]() CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Fundador | - | - |
Corporate Officer/Principal | - | - |
Historial de carrera de Ken Pastor
Antiguos cargos conocidos de Ken Pastor.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CTI Capital Securities, Inc.
![]() CTI Capital Securities, Inc. Investment Banks/BrokersFinance CTI Capital Securities, Inc. (CTI) is the brokerage subsidiary of CTI Capital Groupe, Inc. The firm is headquartered in Montréal and was founded in 1987. CTI provides brokerage services in the fixed-income, money market and stock markets. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. Their equity research focuses on continuous global monitoring of the Canadian stock market. | Analista-Renta Fija | 21/08/2013 | - |
Ventas Institucionales | 21/08/2013 | - | |
CTI Fonds Mutuels
![]() CTI Fonds Mutuels Investment ManagersFinance Founded in 1987, CTI Fond Mutuels is a mutual fund manager headquartered in Montreal, Quebec. The firm is a subsidiary of CTI Capital, Inc. They manage some of the CTI mutual funds. | Analista-Renta Fija | - | 07/12/2010 |
Portfolio Manager-Fixed Income | 07/12/2010 | - | |
Corporate Officer/Principal | 07/12/2010 | 07/12/2010 |
Formación de Ken Pastor.
University of Montréal | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 7 |
Operativa
Analyst-Fixed Income | 2 |
Corporate Officer/Principal | 2 |
Portfolio Manager-Fixed Income | 1 |
Sectorial
Finance | 4 |
Consumer Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
CTI Fonds Mutuels
![]() CTI Fonds Mutuels Investment ManagersFinance Founded in 1987, CTI Fond Mutuels is a mutual fund manager headquartered in Montreal, Quebec. The firm is a subsidiary of CTI Capital, Inc. They manage some of the CTI mutual funds. | Finance |
CTI Capital Securities, Inc.
![]() CTI Capital Securities, Inc. Investment Banks/BrokersFinance CTI Capital Securities, Inc. (CTI) is the brokerage subsidiary of CTI Capital Groupe, Inc. The firm is headquartered in Montréal and was founded in 1987. CTI provides brokerage services in the fixed-income, money market and stock markets. Their fixed-income research seeks to identify the optimal strategy for the term, duration and tactical opportunities between different sectors of the market. Their equity research focuses on continuous global monitoring of the Canadian stock market. | Finance |
GLyPharma Therapeutic, Inc.
![]() GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Finance |
CTI Life Sciences Fund
![]() CTI Life Sciences Fund Miscellaneous Commercial ServicesCommercial Services CTI Life Sciences Fund provides life science related services. The private company is based in Montréal, Canada. The Canadian company was founded in 2006 by Kenneth Pastor. | Commercial Services |
- Bolsa de valores
- Insiders
- Ken Pastor
- Experiencia